Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

InsomniaDiabetesMenopause

Interventions

DRUG

Suvorexant

20mg taken at bedtime for 4 weeks

DRUG

Placebo

placebo taken at bedtime for 4 weeks

Trial Locations (1)

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER